Vivani Medical expects first dosing of SLIM-1 in August 2026

Vivani Medical, Inc.

CEO Dr. Adam Mendelsohn presented at Emerging Growth Conference on July 15, 2026.
First dosing of SLIM-1 clinical trial now expected in August 2026.
Slide presentation used at conference attached as Exhibit 99.1.
No other material financial or operational updates disclosed.

item 7.01 item 9.01

Vivani Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001753926-26-001190

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.